Lectures

Earning CPD by listening to Healthed podcasts is simple. Each episode is eligible for Educational Activities CPD.

Filter results

Learn evidence-based methods for assessing and managing mild-to-moderate acne, including treatment options and patient-specific decision factors.

0.5 EA

Advice and evidence for and role of GLP-1 receptor agonists in the prevention and management of kidney disease in patients with type 2 diabetes will be discussed.

0.5 EA

An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.

0.5 EA

Evidence-based recommendations for managing eczema will be discussed including other relevant issues such as key triggers, managing discoid eczema and when referral might be appropriate.

0.5 EA

Explore "natural oestrogens" as emerging contraceptive options - their biological basis, current evidence, safety claims, and how clinicians can guide patients through informed, evidence-based prescribing decisions.

0.5 EA

This lecture will clarify risk concepts in MHT, helping GPs understand and apply terms like absolute risk and hazard ratios in clinical decision-making.

0.5 EA

A practical and comprehensive framework for the assessment, investigation and management of patients with acutely painful shoulder will be discussed.

Expert/s: Dr Sushil Pant
0.5 EA

The evidence for the effectiveness of new drug options for chronic disease will be discussed, including when, how and in whom they should be prescribed to.

0.5 EA

This lecture equips GPs with practical updates on IPD vaccination - who, when, which vaccine, funding, and high-risk patient groups.

0.5 EA

Dr Ted Wu discussed the opportunities and challenges that future research into cardiovascular outcomes in patients with type 2 diabetes are likely to encounter.

Expert/s: Dr Ted Wu
0.5 EA

This presentation discuss the risk of nutritional deficits and loss of muscle mass associated with the use of GLP-1 receptor agonists and recommendations on how to reduce these risks.

0.5 EA

Changes to the Australian prostate cancer screening guidelines will be discussed including the updated risk: benefit profile for PSA testing, who should be tested and how test results should be interpreted and managed.

Learn evidence-based methods for assessing and managing mild-to-moderate acne, including treatment options and patient-specific decision factors.

Advice and evidence for and role of GLP-1 receptor agonists in the prevention and management of kidney disease in patients with type 2 diabetes will be discussed.

An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.

Evidence-based recommendations for managing eczema will be discussed including other relevant issues such as key triggers, managing discoid eczema and when referral might be appropriate.

Explore "natural oestrogens" as emerging contraceptive options - their biological basis, current evidence, safety claims, and how clinicians can guide patients through informed, evidence-based prescribing decisions.

This lecture will clarify risk concepts in MHT, helping GPs understand and apply terms like absolute risk and hazard ratios in clinical decision-making.

A practical and comprehensive framework for the assessment, investigation and management of patients with acutely painful shoulder will be discussed.

Expert/s: Dr Sushil Pant

The evidence for the effectiveness of new drug options for chronic disease will be discussed, including when, how and in whom they should be prescribed to.

This lecture equips GPs with practical updates on IPD vaccination - who, when, which vaccine, funding, and high-risk patient groups.

Dr Ted Wu discussed the opportunities and challenges that future research into cardiovascular outcomes in patients with type 2 diabetes are likely to encounter.

Expert/s: Dr Ted Wu

This presentation discuss the risk of nutritional deficits and loss of muscle mass associated with the use of GLP-1 receptor agonists and recommendations on how to reduce these risks.

Changes to the Australian prostate cancer screening guidelines will be discussed including the updated risk: benefit profile for PSA testing, who should be tested and how test results should be interpreted and managed.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.